Back to top
more

Global Medical REIT (GMRE)

(Real Time Quote from BATS)

$6.37 USD

6.37
415,565

-0.38 (-5.63%)

Updated Aug 6, 2025 11:24 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: REIT and Equity Trust - Other

Zacks News

Zacks Equity Research

Global Medical REIT (GMRE) Q2 FFO Meet Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and +6.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Global Medical REIT (GMRE) Q1 FFO Meet Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 0.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ashford Hospitality Trust (AHT) Reports Q1 Loss, Lags Revenue Estimates

Ashford Hospitality Trust (AHT) delivered FFO and revenue surprises of -84.91% and 1.82%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alexander's (ALX) Q1 FFO Beat Estimates

Alexander's (ALX) delivered FFO and revenue surprises of 13.73% and 1.94%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

CubeSmart (CUBE) Tops Q1 FFO and Revenue Estimates

CubeSmart (CUBE) delivered FFO and revenue surprises of 3.23% and 2.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Global Medical REIT (GMRE) Soars 6.4%: Is Further Upside Left in the Stock?

Global Medical REIT (GMRE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO per share estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Global Medical REIT (GMRE) Q3 FFO and Revenues Miss Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.35% and 1.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Postal Realty Trust (PSTL) Q3 FFO and Revenues Top Estimates

Postal Realty Trust (PSTL) delivered FFO and revenue surprises of 15.38% and 6.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Prologis (PLD) Q3 FFO Beat Estimates

Prologis (PLD) delivered FFO and revenue surprises of 4.38% and 0.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GMRE vs. CUBE: Which Stock Is the Better Value Option?

GMRE vs. CUBE: Which Stock Is the Better Value Option?

Zacks Equity Research

GMRE vs. CDP: Which Stock Should Value Investors Buy Now?

GMRE vs. CDP: Which Stock Is the Better Value Option?

Zacks Equity Research

GMRE or CDP: Which Is the Better Value Stock Right Now?

GMRE vs. CDP: Which Stock Is the Better Value Option?

Zacks Equity Research

Healthpeak Properties' Stock Rises 31% in 6 Months: Here's How

High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.

Zacks Equity Research

Reasons to Add Healthpeak Properties (DOC) to Your Portfolio Now

High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC).

Zacks Equity Research

GMRE vs. CDP: Which Stock Is the Better Value Option?

GMRE vs. CDP: Which Stock Is the Better Value Option?

Zacks Equity Research

Global Medical REIT (GMRE) Meets Q2 FFO Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 2.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

National Storage (NSA) Q2 FFO and Revenues Lag Estimates

National Storage (NSA) delivered FFO and revenue surprises of -1.59% and 2.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Healthcare Realty Trust (HR) Q2 FFO Match Estimates

Healthcare Realty Trust (HR) delivered FFO and revenue surprises of 0% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

NNN REIT (NNN) Q2 FFO and Revenues Top Estimates

NNN REIT (NNN) delivered FFO and revenue surprises of 1.20% and 0.75%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Customers Bancorp (CUBI) Beats Q2 Earnings and Revenue Estimates

Customers Bancorp (CUBI) delivered earnings and revenue surprises of 2.76% and 7.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Global Medical REIT (GMRE) Q1 FFO and Revenues Miss Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 0.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Diversified Healthcare (DHC) Q1 FFO Match Estimates

Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DiamondRock Hospitality (DRH) Q1 FFO and Revenues Beat Estimates

DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of 6.25% and 2.51%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)

Global Medical REIT (GMRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates

Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 8.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?